Reductil (Sibutramine) Information
121doc will no longer be offering the obesity drug Reductil (sibutramine). This is in accordance to recent guidance from the European Medicines Agency (EMA). If you are currently taking Reductil, you can safely discontinue using the drug at any time. If you have any concerns regarding your weight loss treatment, do not hesitate to contact your pharmacist or doctor. If you are an existing patient, you will receive more information and advice via email in due course.
For additional information please visit the website below:
http://www.ema.europa.eu/pdfs/general/direct/pr/81787609en.pdf
Reductil slimming pills contain the active ingredient Sibutramine hydrochloride monohydrate, an anti-obesity component. Reductil Sibutramine works by affecting neurotransmitters chemicals stored in the brain. Reductil Sibutramine has been manufactured by Abbott and works as an appetite suppressant. Reductil Sibutramine reduces craving for food by human body by working on neurotransmitters in the brain. Reductil (Sibutramine) slimming pills have undergone several clinical studies which have shown that Reductil tablets can really help patients lose weight.
Reductil (Sibutramine) should be avoided by pregnant women as it may be harmful to unborn babies. Patients suffering from hypertension or heart problems should take Reductil Sibutramine only after doctor approves it and you are sure about how Reductil can affect you as usage of Reductil Sibutramine by such patients may result in sudden increase in blood pressure or pulse rate. If you fail to reduce at least 5% of your body weight over a period of 12 weeks, your doctor might ask you to stop taking Reductil.
Reductil Sibutramine is subject to a valid prescription and should be only be administered preceding a full medical consultation. This will also apply if you are looking to purchase the product online, via the completion of a comprehensive questionnaire. The doctor will use your results to determine the best course of action.
Reductil Sibutramine is a licensed obesity treatment method for people with a body mass index (BMI) of 30 or higher, and those with a BMI of 27 or higher who also have other obesity related risk factors, such as type 2 diabetes or high cholesterol. Reductil Sibutramine is only prescribed to people in these categories who have had difficulty achieving or maintaining weight loss of more than five per cent of their body weight over three months, using conventional weight loss programmes alone (eg diet and exercise).
Frequently Asked Questions
|